Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced an enhanced risk monitoring and pharmacovigilance solution with Embase, its ...
London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...
With Embase and PharmaPendium, researchers can monitor pre-clinical, clinical and post-market information from a single search - improving pharmacovigilance and risk monitoring Elsevier, a ...
Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results